|
|
|
Content :
News 2006
Press releases are intended for journalists, investors and shareholders.
-
December 15, 2006
Sanofi-aventis response to PBAC rejection of docetaxel in prostate cancer
-
October 31, 2006
First 9 months of 2006: Sales growth of 2.6% on a comparable basis - Adjusted EPS growth of 15.0%, or 7.5% excluding selected items
-
October 26, 2006
New Head of sanofi-aventis Communications Department
-
October 10, 2006
Sanofi-aventis strengthens its commitment with the World Health Organization (WHO) to fight neglected tropical diseases
-
October 02, 2006
Childhood Cancers: Second Call for Projects « My child matters »
-
August 25, 2006
sanofi–aventis’ LANTUS® listed on the PBS
-
August 24, 2006
Lantus to be listed on the PBS - A Media Release from the Minister for Health and Ageing
-
August 02, 2006
First half of 2006: Sales growth of 7.7% on a reported basis and 4.5% on a comparable basis - Adjusted EPS growth of 32.9%, or 16.1% excluding selected items
-
June 01, 2006
General Meeting of Shareholders
-
May 05, 2006
First quarter of 2006: Sales growth of 9.6% on a reported basis and 4.9% on a comparable basis. 52.8% growth in adjusted EPS and 19.8% excluding selected items.
|
|